Document is current
Any future updates will be listed below
-
Authors
Guo, Chunying
Wang, Ting
Huang, Haiyan
Wang, Xiaolu
Jiang, Yugui
Li, Jinan
- License Information
-
More Information
Article History
Received: 7 November 2023
Accepted: 8 April 2024
First Online: 13 April 2024
Competing interests
: J.L. founded the Talengen Institute of Life Sciences and Talengen Laboratory of Sciences. The Institutes have applied for/obtained patents on the use of plasminogen for the treatment of Parkinson’s disease and other neurological diseases and are developing natural and recombinant plasminogen as a drug candidate. The other authors have declared no competing interests.
